Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26687836

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2016 Jan
First author
Patrikidou A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2016 May;58:38-40. doi: 10.1016/j.ejca.2016.01.018.
    note
    Source null
    related pmid
    26933960
    relationship
    Comment in

Authors and identifiers

  1. name
    Patrikidou A
    type
    Author
  2. name
    Domont J
    type
    Author
  3. name
    Chabaud S
    type
    Author
  4. name
    Ray-Coquard I
    type
    Author
  5. name
    Coindre JM
    type
    Author
  6. name
    Bui-Nguyen B
    type
    Author
  7. name
    Adenis A
    type
    Author
  8. name
    Rios M
    type
    Author
  9. name
    Bertucci F
    type
    Author
  10. name
    Duffaud F
    type
    Author
  11. name
    Chevreau C
    type
    Author
  12. name
    Cupissol D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Patrikidou A
    type
    Author
  2. name
    Domont J
    type
    Author
  3. name
    Chabaud S
    type
    Author
  4. name
    Ray-Coquard I
    type
    Author
  5. name
    Coindre JM
    type
    Author
  6. name
    Bui-Nguyen B
    type
    Author
  7. name
    Adenis A
    type
    Author
  8. name
    Rios M
    type
    Author
  9. name
    Bertucci F
    type
    Author
  10. name
    Duffaud F
    type
    Author
  11. name
    Chevreau C
    type
    Author
  12. name
    Cupissol D
    type
    Author
bibliography ids
  1. nci-bib-b714fac45f26427d48a53435
book metadata
content sha256
cbc48238b05f64d61f5eb128ec69614ee59a4f041973a8382f0007258347ad82
document type
citation
dois
  1. 10.1016/j.ejca.2015.10.069
electronic publication date
display
2015 Dec 11
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26687836
immutable id
pubmed:26687836@cbc48238b05f64d61f5eb128ec69614ee59a4f041973a8382f0007258347ad82
journal
abbreviation
Eur J Cancer
issn electronic
1879-0852
issn print
0959-8049
issue
Source null
name
European journal of cancer (Oxford, England : 1990)
nlm unique id
9005373
pages
173-80
volume
52
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur J Cancer. 2016 May;58:38-40. doi: 10.1016/j.ejca.2016.01.018.
    note
    Source null
    related pmid
    26933960
    relationship
    Comment in
outcomes validated
false
pmid
26687836
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
0252d1f98f7d7d4d1120827cf0777e9d99245478f3216a6cd72eb652cb3dc55e
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Jan
precision
month
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26687836/
title
Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group.

Preserved source evidence · Not medical advice